Neuro-oncology focuses on the biology, diagnosis, and treatment of tumors that affect the brain, spinal cord, and peripheral nervous system. It integrates oncology, neurosurgery, molecular genetics, and imaging to improve survival and life quality for patients with CNS tumors.

The Neuro-Oncology session covers gliomas, meningiomas, medulloblastomas, and metastatic brain tumors. Researchers explore pathogenesis, molecular profiling, and therapeutic advances including immunotherapy and targeted drug delivery.

At the Neuro-Oncology Conference, oncologists, radiologists, and neuroscientists present clinical trials, AI-assisted diagnostics, and precision medicine approaches. Participants also discuss novel surgical techniques, proton therapy, and liquid biopsies for early detection.

This session attracts clinicians and researchers interested in translating bench discoveries into effective patient care. Attendees gain insight into tumor microenvironments, genomic landscapes, and multimodal treatment strategies.

Recent advances in Brain Tumors research demonstrate how multi-omics profiling and AI tools enhance tumor classification and therapeutic decision-making.